Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Alzheimer DementiaAgitation,Psychomotor
Interventions
DEVICE

Electroconvulsive Therapy (ECT)

Stimulus method of delivery will be RUL electrode placement, and ultra-brief (UB) pulse width (0.25-0.37ms). At the first ECT session, seizure threshold (ST) will be determined by titration with the empirical dose titration method and subsequent treatments will be approximately 6 times the ST. Following other NIMH sponsored multicenter ECT studies (PRIDE, U01 MH055495), stimulus settings will be adjusted as needed during the ECT course based on seizure quality and treatment efficacy. Participants will be administered anesthesia.

Trial Locations (5)

11004

RECRUITING

Northwell Health, Glen Oaks

30308

RECRUITING

Emory Healthcare, Atlanta

49548

RECRUITING

Pine Rest Christian Mental Health Services, Grand Rapids

55905

RECRUITING

Mayo Clinic, Rochester

02478

RECRUITING

McLean Hospital, Belmont

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Pine Rest Christian Mental Health Services

OTHER

collaborator

Emory University

OTHER

collaborator

The Zucker Hillside Hospital

OTHER

collaborator

Medical University of South Carolina

OTHER

lead

Brent Forester

OTHER

NCT03926520 - Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) | Biotech Hunter | Biotech Hunter